Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy-Reference-Cited by-同舟云学术

Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy

Published:2024-02-01 Issue:5 Volume:67 Page:996-1009
ISSN:1674-7305
Container-title:Science China Life Sciences
language:en
Short-container-title:Sci. China Life Sci.

Author:

Zhou Xiaowen,Li Yang,Zhang Xiangrui,Li Beibei,Jin Shengzhe,Wu Menghan,Zhou Xiuman,Dong Qingyu,Du Jiangfeng,Zhai Wenjie,Wu Yahong,Qiu Lu,Li Guodong,Qi Yuanming,Zhao Wenshan,Gao Yanfeng

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11427-023-2472-4.pdf

Reference57 articles.

1. Aaes, T.L., and Vandenabeele, P. (2021). The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses. Cell Death Differ 28, 843–860.

2. Almahi, W.A., Yu, K.N., Mohammed, F., Kong, P., and Han, W. (2022). Hemin enhances radiosensitivity of lung cancer cells through ferroptosis. Exp Cell Res 410, 112946.

3. Bagchi, S., Yuan, R., and Engleman, E.G. (2021). Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu Rev Pathol Mech Dis 16, 223–249.

4. Banesh, S., Layek, S., and Trivedi, V. (2022). Hemin acts as CD36 ligand to activate down-stream signalling to disturb immune responses and cytokine secretion from macrophages. Immunol Lett 243, 1–18.

5. Banta, K.L., Xu, X., Chitre, A.S., Au-Yeung, A., Takahashi, C., O’Gorman, W.E., Wu, T.D., Mittman, S., Cubas, R., Comps-Agrar, L., et al. (2022). Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses. Immunity 55, 512–526.e9.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects;Apoptosis;2024-07-15

2. Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities;Antioxidants;2024-06-28

3. Development of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation;Molecules;2024-04-22